Tenofovir Plasma Concentration From Pre-Exposure Prophylaxis (PrEP) at the Time of Potential HIV Exposure: A Population Pharmacokinetic Modeling and Simulation Study Involving Serodiscordant Couples in East Africa

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00446-19
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

HIV Pre-Exposure Prophylaxis (PrEP): Effective but Controversial

Trends in Urology & Men's Health
2017English

Intimate Partner Violence and Adherence to HIV Pre-Exposure Prophylaxis (PrEP) in African Women in HIV Serodiscordant Relationships

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Tenofovir-Based Pre-Exposure Prophylaxis for HIV Prevention

Current Opinion in Infectious Diseases
Infectious DiseasesMicrobiology
2012English

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2016English

Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) in Preventing HIV-1 Infections in Rural Zambia: A Modeling Study

PLoS ONE
Multidisciplinary
2013English

Tenofovir Pre-Exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time Is Now

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2016English

HIV Pre-Exposure Prophylaxis

CMAJ
Medicine
2014English

Evaluating the Cost-Effectiveness of Pre-Exposure Prophylaxis (PrEP) and Its Impact on HIV-1 Transmission in South Africa

PLoS ONE
Multidisciplinary
2010English

Knowledge, Attitudes, and Experiences of HIV Pre-Exposure Prophylaxis (PrEP) Trial Participants in Botswana

World Journal of AIDS
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy